72 related articles for article (PubMed ID: 522828)
21. Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age.
Basso D; Fabris C; Del Favero G; Angonese C; Meggiato T; Infantino A; Plebani M; Piccoli A; Leandro G; Burlina A
Dis Markers; 1988; 6(3):203-7. PubMed ID: 3168400
[TBL] [Abstract][Full Text] [Related]
22. [Radioimmunologic determination of carcinoembryonic antigen (CEA). Current viewpoints and personal experience].
Lupo A
Minerva Dietol Gastroenterol; 1978; 24(2):89-96. PubMed ID: 733032
[No Abstract] [Full Text] [Related]
23. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE
Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474
[TBL] [Abstract][Full Text] [Related]
24. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
Ivanov PK; Samoĭlenko VM
Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic oncofoetal antigen (POA): its frequency and localisation in humans.
Hobbs JR; Knapp ML; Branfoot AC
Oncodev Biol Med; 1980 Aug; 1(1):37-48. PubMed ID: 7279697
[TBL] [Abstract][Full Text] [Related]
26. The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer.
Zamcheck N
Clin Gastroenterol; 1976 Sep; 5(3):625-38. PubMed ID: 1022377
[No Abstract] [Full Text] [Related]
27. [Tumor markers of pancreatic cancer].
Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
[TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
Zamcheck N
Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
[No Abstract] [Full Text] [Related]
29. [The diagnosis of pancreatic carcinoma by combined endoscopic retrograde pancreatiography, aspiration cytology and carcinoembryonic antigen determination in the pancreatic secretion (author's transl)].
Brandstäter G; Kratochvil P; Wiedner F; Justich E; Fladerer H
Wien Klin Wochenschr; 1978 May; 90(10):347-50. PubMed ID: 654299
[TBL] [Abstract][Full Text] [Related]
30. Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft.
Tan MH; Shimano T; Chu TM
J Natl Cancer Inst; 1981 Sep; 67(3):563-9. PubMed ID: 6944528
[TBL] [Abstract][Full Text] [Related]
31. Carcinoembryonic antigen assay in fine needle aspirate of pancreas: a diagnostic adjunct to cytology.
Pinto MM; Levine RH
Am J Gastroenterol; 1992 Apr; 87(4):530-3. PubMed ID: 1553944
[TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen and the liver.
Loewenstein MS; Zamcheck N
Gastroenterology; 1977 Jan; 72(1):161-6. PubMed ID: 830231
[No Abstract] [Full Text] [Related]
33. Proceedings: Can carcinoembryonic antigen (CEA) differentiate carcinoma pancreas from chronic pancreatitis?
Dilawari JB; Blendis LM; Waller SL; Mackay A; Neville AM
Gut; 1973 Oct; 14(10):827-8. PubMed ID: 4758696
[No Abstract] [Full Text] [Related]
34. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
Kuroki M; Ichiki S; Kuroki M; Matsuoka Y
J Natl Cancer Inst; 1982 Aug; 69(2):401-8. PubMed ID: 6810002
[TBL] [Abstract][Full Text] [Related]
35. Demonstration and immunochemical characterization of carcinoembryonic antigen in human pancreatic juice.
McCabe RP; Kupchik HZ; Saravis CA; Broitman SA; Gregg JA; Zamcheck N
J Natl Cancer Inst; 1976 May; 56(5):885-9. PubMed ID: 825652
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
38. Tumor marker secretion (CA 19-9, CEA, CA 125) by xenografts of eight different human pancreatic carcinomas compared to the human tumors.
Klapdor R; Harms F; Bahlo M; Arps H; Dietel M
Strahlenther Onkol; 1989 Jul; 165(7):496-7. PubMed ID: 2749476
[No Abstract] [Full Text] [Related]
39. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic markers of pancreatic cancer in humans].
Kulagin PP; Chalov VV
Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
